These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 16413468

  • 1. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
    Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW.
    Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
    Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP.
    Cancer Res; 2005 Nov 15; 65(22):10174-8. PubMed ID: 16288002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, Knowles DM, Lane J, Chen-Kiang S.
    Cancer Res; 2005 Dec 15; 65(24):11345-53. PubMed ID: 16357141
    [Abstract] [Full Text] [Related]

  • 7. The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development.
    Landis MW, Brown NE, Baker GL, Shifrin A, Das M, Geng Y, Sicinski P, Hinds PW.
    Cancer Res; 2007 Aug 15; 67(16):7613-20. PubMed ID: 17699765
    [Abstract] [Full Text] [Related]

  • 8. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG.
    Oncogene; 2002 Jan 10; 21(2):291-8. PubMed ID: 11803472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV.
    Cancer Res; 2001 Dec 15; 61(24):8811-9. PubMed ID: 11751403
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
    Scimè A, Li L, Ciavarra G, Whyte P.
    J Cell Physiol; 2008 Mar 15; 214(3):568-81. PubMed ID: 17894419
    [Abstract] [Full Text] [Related]

  • 12. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 13. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 14. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.
    Casimiro MC, Velasco-Velázquez M, Aguirre-Alvarado C, Pestell RG.
    Expert Opin Investig Drugs; 2014 Mar 28; 23(3):295-304. PubMed ID: 24387133
    [Abstract] [Full Text] [Related]

  • 15. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H, Sylvestre JR, Jolicoeur P.
    Oncogene; 2010 Aug 12; 29(32):4543-54. PubMed ID: 20562911
    [Abstract] [Full Text] [Related]

  • 16. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK, Luo L, Medina D.
    Carcinogenesis; 1995 Oct 12; 16(10):2507-13. PubMed ID: 7586159
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of cytoplasmic cyclin D1 mutants.
    Murakami H, Horihata M, Andojo S, Yoneda-Kato N, Kato JY.
    FEBS Lett; 2009 May 19; 583(10):1575-80. PubMed ID: 19409388
    [Abstract] [Full Text] [Related]

  • 18. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.
    Kundumani-Sridharan V, Singh NK, Kumar S, Gadepalli R, Rao GN.
    J Biol Chem; 2013 Jul 26; 288(30):22150-62. PubMed ID: 23737530
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
    Law M, Forrester E, Chytil A, Corsino P, Green G, Davis B, Rowe T, Law B.
    Cancer Res; 2006 Jan 15; 66(2):1070-80. PubMed ID: 16424043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.